These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3414517)

  • 1. Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation.
    Shenasa M; Kus T; Fromer M; LeBlanc RA; Dubuc M; Nadeau R
    Am J Cardiol; 1988 Sep; 62(7):403-7. PubMed ID: 3414517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
    Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
    Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
    Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure.
    Heywood JT
    Can J Cardiol; 1995 Oct; 11(9):823-6. PubMed ID: 7585281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of diltiazem and esmolol on cycle length and spontaneous conversion of atrial fibrillation.
    Sticherling C; Tada H; Hsu W; Bares AC; Oral H; Pelosi F; Knight BP; Strickberger SA; Morady F
    J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):81-8. PubMed ID: 12075396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing.
    Horjen AW; Ulimoen SR; Enger S; Norseth J; Seljeflot I; Arnesen H; Tveit A
    BMC Cardiovasc Disord; 2016 May; 16():79. PubMed ID: 27142292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
    Aronow WS
    Cardiol Rev; 2008; 16(4):181-8. PubMed ID: 18562808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of atrial fibrillation to sinus rhythm during treatment with intravenous esmolol or diltiazem: a prospective, randomized comparison.
    Hassan S; Slim AM; Kamalakannan D; Khoury R; Kakish E; Maria V; Ahmed S; Pires LA; Kronick SL; Oral H; Morady F
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):227-31. PubMed ID: 17875950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs.
    Bénardeau A; Fareh S; Nattel S
    Cardiovasc Res; 2001 Apr; 50(1):85-96. PubMed ID: 11282081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans.
    Daoud EG; Knight BP; Weiss R; Bahu M; Paladino W; Goyal R; Man KC; Strickberger SA; Morady F
    Circulation; 1997 Sep; 96(5):1542-50. PubMed ID: 9315545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of ventricular rate in permanent atrial fibrillation: randomized, crossover study of the effects of slow-release formulations of gallopamil, diltiazem, or verapamil.
    Botto GL; Bonini W; Broffoni T
    Clin Cardiol; 1998 Nov; 21(11):837-40. PubMed ID: 9825197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravenous diltiazem in the reversion to sinus rhythm in supraventricular tachyarrhythmias].
    Luciardi H; Berman S; Santana M; Monteros L
    Arch Inst Cardiol Mex; 1996; 66(6):505-9. PubMed ID: 9133311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation.
    Chiladakis JA; Stathopoulos C; Davlouros P; Manolis AS
    Int J Cardiol; 2001 Jul; 79(2-3):287-91. PubMed ID: 11461753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation.
    Ulimoen SR; Enger S; Carlson J; Platonov PG; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
    Am J Cardiol; 2013 Jan; 111(2):225-30. PubMed ID: 23111138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil.
    Lundström T; Rydén L
    J Am Coll Cardiol; 1990 Jul; 16(1):86-90. PubMed ID: 2358610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral L-type calcium channel blocker on repetitive paroxysmal atrial fibrillation: spectral analysis of fibrillation waves in the Holter monitoring.
    Niwano S; Fukaya H; Sasaki T; Hatakeyama Y; Fujiki A; Izumi T
    Europace; 2007 Dec; 9(12):1209-15. PubMed ID: 17897926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of supraventricular tachyarrhythmias with intravenous calcium channel blockers: are subtle differences worth the cost?
    Cheiman DM; Shea BF; Kelly RA
    Pharmacotherapy; 1996; 16(5):861-8. PubMed ID: 8888080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem.
    Lewis RV; Irvine N; McDevitt DG
    Eur Heart J; 1988 Jul; 9(7):777-81. PubMed ID: 3169046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.